Related Experiment Video
Updated: Jul 19, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Pharmacological interventions for bipolar youth: developmental considerations.
Melissa P DelBello1, Robert A Kowatch
1Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267-0559, USA. delbelmp@email.uc.edu
Development and Psychopathology
|October 27, 2006
Summary
Few controlled studies exist for pediatric bipolar disorder treatments. Research is growing for mania, but depression and prevention require more investigation in youth.
Area of Science:
- Child and Adolescent Psychiatry
- Pharmacology
- Mental Health Research
Background:
- Bipolar disorder affects children and adolescents, yet controlled studies on pharmacological treatments are limited.
- Clinical characteristics of pediatric bipolar disorder differ from adults.
- Co-occurring conditions like ADHD are common, complicating treatment decisions.
Purpose of the Study:
- To review pharmacological treatments for pediatric bipolar disorder.
- To examine treatment effectiveness in those at familial risk.
- To discuss emerging research on prodromal symptoms and early interventions.
Main Methods:
- Systematic review of extant literature on pharmacological interventions.
- Analysis of controlled studies focusing on manic, mixed, and depressive episodes.
- Exploration of research on familial risk and early intervention strategies.
Main Results:
- Controlled studies for manic/mixed episodes in youth are increasing.
- Limited research exists for treating depression and preventing recurrent episodes in this population.
- Data guiding treatment for comorbid conditions remains scarce.
Conclusions:
- More controlled studies are needed for pediatric bipolar disorder, especially for depression and prevention.
- Early intervention strategies for at-risk youth are an emerging area of research.
- Addressing co-occurring disorders is crucial for effective treatment in children and adolescents.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...